Matches in SemOpenAlex for { <https://semopenalex.org/work/W2238487808> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2238487808 endingPage "10" @default.
- W2238487808 startingPage "1603" @default.
- W2238487808 abstract "To determine the relative role of endogenous prostaglandin F2 alpha (PGF2 alpha) secretion in cloprostenol-induced abortion in mares that no longer require luteal progesterone secretion for maintenance of pregnancy, and to evaluate the ability of a prostaglandin cyclooxygenase inhibitor (flunixin meglumine) to prevent cloprostenol-induced abortion.The effect of flunixin meglumine on PGF2 alpha secretion and outcome of pregnancy was compared between mares treated with cloprostenol only and mares treated with cloprostenol plus flunixin meglumine.Five pregnant mares, aged 4 to 15 years, of light-horse type.Cloprostenol (250 micrograms) was administered at 24-hour intervals to 5 pregnant mares. Flunixin meglumine (500 mg, IV) was administered at 8-hour intervals starting 15 minutes before the first cloprostenol administration. Hourly blood samples were analyzed for 15-ketodihydro-PGF2 alpha, progesterone, and estrogen concentrations. Previously reported data on cloprostenol-induced abortion in 6 pregnant mares treated daily with cloprostenol only were used as historic controls.The mean (+/- SEM) interval from first cloprostenol administration to fetal expulsion 56.4 (+/- 13.7) hours and number of cloprostenol administrations 3.2 (+/- 0.6) in the 5 flunixin meglumine-treated mares were not significantly different, compared with values for 6 pregnant mares treated daily with cloprostenol only, 48.6 (+/- 5.6) hours and 2.8 (+/- 0.2) cloprostenol administrations. Flunixin meglumine did not inhibit endogenous PGF2 alpha secretion. Prostaglandin F2 alpha secretion rates on the day before and day of fetal expulsion were similar in both groups.Flunixin meglumine at a dosage of 500 mg/animal, administered IV every 8 hours, is ineffective in modulating uterine PGF2 alpha secretion during cloprostenol-induced abortion.Flunixin meglumine is ineffective in the modulation of prostaglandin-induced uterine PGF2 alpha secretion and, therefore, does not offer a viable alternative for the prevention of abortion in mares at risk of abortion because of systemic illness." @default.
- W2238487808 created "2016-06-24" @default.
- W2238487808 creator A5021414175 @default.
- W2238487808 creator A5031295920 @default.
- W2238487808 creator A5032713723 @default.
- W2238487808 creator A5066554113 @default.
- W2238487808 date "1995-12-01" @default.
- W2238487808 modified "2023-09-26" @default.
- W2238487808 title "Effect of flunixin meglumine on endogenous prostaglandin F2 alpha secretion during cloprostenol-induced abortion in mares." @default.
- W2238487808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8599521" @default.
- W2238487808 hasPublicationYear "1995" @default.
- W2238487808 type Work @default.
- W2238487808 sameAs 2238487808 @default.
- W2238487808 citedByCount "4" @default.
- W2238487808 countsByYear W22384878082012 @default.
- W2238487808 crossrefType "journal-article" @default.
- W2238487808 hasAuthorship W2238487808A5021414175 @default.
- W2238487808 hasAuthorship W2238487808A5031295920 @default.
- W2238487808 hasAuthorship W2238487808A5032713723 @default.
- W2238487808 hasAuthorship W2238487808A5066554113 @default.
- W2238487808 hasConcept C126322002 @default.
- W2238487808 hasConcept C134018914 @default.
- W2238487808 hasConcept C1998276 @default.
- W2238487808 hasConcept C2777284740 @default.
- W2238487808 hasConcept C2777702977 @default.
- W2238487808 hasConcept C2778642596 @default.
- W2238487808 hasConcept C2779234561 @default.
- W2238487808 hasConcept C2779526769 @default.
- W2238487808 hasConcept C2780664492 @default.
- W2238487808 hasConcept C54355233 @default.
- W2238487808 hasConcept C71315377 @default.
- W2238487808 hasConcept C71924100 @default.
- W2238487808 hasConcept C86803240 @default.
- W2238487808 hasConceptScore W2238487808C126322002 @default.
- W2238487808 hasConceptScore W2238487808C134018914 @default.
- W2238487808 hasConceptScore W2238487808C1998276 @default.
- W2238487808 hasConceptScore W2238487808C2777284740 @default.
- W2238487808 hasConceptScore W2238487808C2777702977 @default.
- W2238487808 hasConceptScore W2238487808C2778642596 @default.
- W2238487808 hasConceptScore W2238487808C2779234561 @default.
- W2238487808 hasConceptScore W2238487808C2779526769 @default.
- W2238487808 hasConceptScore W2238487808C2780664492 @default.
- W2238487808 hasConceptScore W2238487808C54355233 @default.
- W2238487808 hasConceptScore W2238487808C71315377 @default.
- W2238487808 hasConceptScore W2238487808C71924100 @default.
- W2238487808 hasConceptScore W2238487808C86803240 @default.
- W2238487808 hasIssue "12" @default.
- W2238487808 hasLocation W22384878081 @default.
- W2238487808 hasOpenAccess W2238487808 @default.
- W2238487808 hasPrimaryLocation W22384878081 @default.
- W2238487808 hasRelatedWork W1976992891 @default.
- W2238487808 hasRelatedWork W2024552239 @default.
- W2238487808 hasRelatedWork W2069739082 @default.
- W2238487808 hasRelatedWork W2078066527 @default.
- W2238487808 hasRelatedWork W2085607800 @default.
- W2238487808 hasRelatedWork W2168622122 @default.
- W2238487808 hasRelatedWork W2278885203 @default.
- W2238487808 hasRelatedWork W2330865378 @default.
- W2238487808 hasRelatedWork W2996626904 @default.
- W2238487808 hasRelatedWork W2151006525 @default.
- W2238487808 hasVolume "56" @default.
- W2238487808 isParatext "false" @default.
- W2238487808 isRetracted "false" @default.
- W2238487808 magId "2238487808" @default.
- W2238487808 workType "article" @default.